SlideShare une entreprise Scribd logo
1  sur  57
Télécharger pour lire hors ligne
NYC	
  RxStat:	
  A	
  Collabora0ve	
  
Approach	
  to	
  Surveillance	
  of	
  
Prescrip0on	
  Drug	
  Misuse	
  and	
  
Associated	
  	
  Consequences	
  
April	
  23,	
  2014	
  
Atlanta	
  Marrio2	
  Marquis	
  
1	
  
Learning	
  Objec0ves	
  
1.  Describe	
  how	
  public	
  health/public	
  safety	
  
partnership	
  informs	
  City’s	
  response	
  to	
  opioid	
  
analgesic	
  misuse	
  
2.  Real-­‐Gme	
  data	
  in	
  acGon:	
  Use	
  Gmely	
  data	
  to	
  
shape	
  response	
  to	
  public	
  health	
  events	
  
3.  Data-­‐driven	
  policy:	
  Use	
  data	
  to	
  inform	
  City’s	
  
opioid-­‐related	
  policies	
  and	
  strategies	
  
2	
  
Disclosure	
  Statement	
  
Steven	
  Newmark,	
  Michelle	
  Nolan,	
  Michael	
  
Clarke,	
  Alexandra	
  Harocopos	
  and	
  Ellenie	
  Tuazon	
  
have	
  no	
  financial	
  relaGonships	
  with	
  proprietary	
  
enGGes	
  that	
  produce	
  health	
  care	
  goods	
  and	
  
services	
  
3	
  
Outline	
  
•  RxStat	
  Overview	
  
(Steven	
  Newmark,	
  NYC	
  Office	
  of	
  the	
  Mayor)	
  
•  Public	
  Health	
  Data	
  Sources	
  
(Michelle	
  Nolan,	
  NYC	
  Dept.	
  of	
  Health	
  and	
  Mental	
  Hygiene)	
  
•  Public	
  Safety	
  Data	
  Sources	
  
(Michael	
  Clarke,	
  NYC	
  Mayor’s	
  Office	
  of	
  Criminal	
  JusFce)	
  
•  Opioid	
  Analgesics	
  in	
  New	
  York	
  City:	
  A	
  Qualita0ve	
  Study	
  
(Alexandra	
  Harocopos,	
  NYC	
  Dept.	
  of	
  Health	
  and	
  Mental	
  Hygiene)	
  
•  Data	
  Driven	
  Opioid	
  Policies	
  and	
  Strategies	
  in	
  New	
  York	
  City	
  	
  
(Ellenie	
  Tuazon,	
  NYC	
  Dept.	
  of	
  Health	
  and	
  Mental	
  Hygiene)	
  
4	
  
RXSTAT	
  OVERVIEW	
  
Steven	
  Newmark,	
  JD/MPA,	
  Sr.	
  Policy	
  Advisor	
  &	
  Counsel	
  to	
  the	
  Deputy	
  
Mayor	
  for	
  Health	
  and	
  Human	
  Services	
  
New	
  York	
  City	
  Office	
  of	
  the	
  Mayor	
  
5	
  
Opioid	
  Analgesics	
  Are	
  a	
  Public	
  Health	
  Crisis	
  in	
  	
  
New	
  York	
  City	
  
*Paone D, Bradley O’Brien D, Shah S, Heller D. Opioid analgesics in New York City: misuse, morbidity and
mortality update. Epi Data Brief. April 2011. Available at
http://www.nyc.gov/html/doh/downloads/pdf/epi/epi-data-brief.pdf .
6	
  
RxStat:	
  Central	
  Focus	
  and	
  Unifying	
  Goal	
  
Reduce	
  
Overdose	
  
Deaths	
  
7	
  
RxStat:	
  Four	
  Core	
  Principles	
  
•  Timely,	
  accurate	
  analysis	
  of	
  drug	
  misuse	
  
indicators	
  from	
  mulGple	
  sources	
  (e.g.,	
  mortality,	
  
EDs,	
  PMP,	
  drug	
  treatment,	
  law	
  enforcement,	
  etc.)	
  
•  Develop	
  strategies	
  based	
  on	
  analysis	
  of	
  exisGng	
  
and	
  newly	
  available	
  data	
  
•  Rapid	
  deployment	
  of	
  public	
  health	
  and	
  public	
  
safety	
  resources	
  to	
  high	
  priority	
  areas	
  
•  Rigorous	
  follow-­‐up	
  to	
  ensure	
  strategies	
  are	
  
effecGve	
  
8	
  
RxStat	
  
•  Public	
  health	
  &	
  public	
  safety	
  collaboraGon	
  
– Housed	
  at	
  NYC	
  Department	
  of	
  Health	
  &	
  Mental	
  
Hygiene	
  (DOHMH)	
  leverages	
  experGse	
  and	
  
infrastructure	
  	
  
•  “Real-­‐Gme”	
  (enhanced)	
  surveillance	
  
•  ParGcipants	
  and	
  stakeholders	
  at	
  city,	
  state,	
  
and	
  federal	
  organizaGons	
  	
  
•  Monthly	
  RxStat	
  Data	
  MeeGngs	
  
9	
  
Layering	
  and	
  Repor0ng	
  Data	
  
Reduce	
  
Overdose	
  
Deaths	
  
10	
  
Data	
  Sources	
  
Reduce	
  
Overdose	
  
Deaths	
  
PMP	
  
Data	
  
Treatment	
  	
  
Admissions	
  
Poison	
  
Control	
  
Drug	
  
ProsecuGons	
  
HospitalizaGons	
  
Jail	
  
Data	
  
Mortality	
  
DEA	
  
ARCOS	
  
Pharmacy	
  
Crime	
  
Price/Purity	
  
QualitaGve	
  
Research	
   Medicaid	
  
Fraud	
  Data	
  
Syndromic	
  
QualitaGve	
  
Research	
  
Mortality	
  
Pharmacy	
  
Crime	
  
DEA	
  
ARCOS	
  
Drug	
  
ProsecuGons	
  
11	
  
PUBLIC	
  HEALTH	
  DATA	
  SOURCES	
  
Michelle	
  Nolan,	
  MPH,	
  RxStat	
  Data	
  Analyst	
  
New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  
12	
  
Outline	
  
•  Describe	
  opioid	
  analgesic	
  use	
  and	
  misuse	
  in	
  
New	
  York	
  City	
  
•  Discuss	
  an	
  example	
  of	
  how	
  real-­‐Gme	
  data	
  was	
  
used	
  to	
  inform	
  a	
  public	
  health	
  response	
  
13	
  
Opioid	
  Analgesic	
  Use	
  and	
  Misuse	
  in	
  NYC	
  
•  In	
  2012,	
  700,000	
  New	
  Yorkers	
  filled	
  more	
  than	
  
2	
  million	
  opioid	
  analgesic	
  prescripGons	
  	
  
•  In	
  2010-­‐2011,	
  4%	
  (162,000)	
  of	
  New	
  Yorkers	
  
aged	
  12	
  and	
  older	
  reported	
  past	
  year	
  opioid	
  
analgesic	
  misuse	
  
•  In	
  2011,	
  the	
  rate	
  of	
  emergency	
  department	
  
visits	
  a2ributed	
  to	
  opioid	
  analgesic	
  misuse/
abuse	
  was	
  141.3/100,000	
  New	
  Yorkers	
  
14	
  
Opioids	
  Were	
  Involved	
  In	
  73%	
  of	
  Overdose	
  
Deaths	
  in	
  NYC	
  
0
100
200
300
400
500
600
700
800
900
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Number
Year of Death
Total
Opioids
Heroin
Opioid
Analgesics
NOTE:	
  Drugs	
  not	
  mutually	
  exclusive	
  
Source: New York City Office of the Chief Medical Examiner & New
York City Department of Health and Mental Hygiene 2000-2012
15	
  
59 66
78 81
93
130
152
131 137
151
173
220
201
0.9
1
1.3 1.3
1.5
2
2.4
2
2.1
2.3
2.6
3.3
3.0
0
0.5
1
1.5
2
2.5
3
3.5
0
50
100
150
200
250
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Age-adjustedrateper100,000
Number
Number of unintentional opioid analgesic poisoning deaths
Age-adjusted rate per 100,000
Opioid	
  Analgesic	
  Overdose	
  Deaths	
  Increased	
  233%	
  from	
  
2000	
  to	
  2012,	
  NYC	
  
Source: New York City Office of the Chief Medical Examiner & New
York City Department of Health and Mental Hygiene 2000-2012
16	
  
373
416 400
438
358
379 388
301 317
288
209
284
382
5.9
6.3 6.3
6.9
5.7
5.9
6.1
4.7
4.9
4.4
3.1
4.2
5.7
0
1
2
3
4
5
6
7
8
0
50
100
150
200
250
300
350
400
450
500
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Age-adjustedrateper100,000
Number
Number of unintentional heroin poisoning deaths
Age-adjusted rate per 100,000
Heroin	
  Overdose	
  Deaths	
  Increased	
  84%	
  from	
  	
  
2010	
  to	
  2012,	
  NYC	
  
Source: New York City Office of the Chief Medical Examiner & New
York City Department of Health and Mental Hygiene 2000-2012
17	
  
What	
  About	
  Heroin?	
  
•  Increases	
  in	
  heroin-­‐related	
  overdose	
  deaths	
  beginning	
  
in	
  2011	
  preceded	
  decreases	
  in	
  opioid	
  analgesic-­‐related	
  
overdose	
  deaths	
  in	
  2012	
  	
  
•  Similarly	
  the	
  increase	
  in	
  heroin	
  deaths	
  in	
  New	
  York	
  City	
  
aher	
  2010	
  was	
  not	
  preceded	
  by	
  a	
  decrease	
  in	
  the	
  
prescribing	
  of	
  opioid	
  analgesics,	
  suggesGng	
  that	
  the	
  
heroin	
  overdose	
  increase	
  occurred	
  independent	
  of	
  any	
  
changes	
  in	
  prescripGon	
  opioid	
  availability	
  
18	
  
Emergency	
  Ac0on	
  Plan	
  
•  Early	
  January,	
  2014:	
  Mid-­‐AtlanGc	
  and	
  
Northeast	
  states	
  reported	
  an	
  increase	
  in	
  the	
  
number	
  of	
  overdoses	
  related	
  to	
  heroin	
  
containing	
  fentanyl	
  
•  February,	
  2014:	
  Mass	
  media	
  coverage	
  of	
  
heroin	
  following	
  the	
  death	
  of	
  a	
  public	
  figure	
  in	
  
New	
  York	
  City	
  
19	
  
Within	
  24	
  Hours:	
  	
  
•  NYC	
  DOHMH	
  data	
  review	
  of:	
  
– Syndromic	
  surveillance	
  
•  No	
  detectable	
  increase	
  in	
  the	
  number	
  of	
  
emergency	
  department	
  visits	
  for	
  overdose	
  
– Poison	
  Control	
  Data	
  
•  No	
  increase	
  in	
  the	
  number	
  of	
  consultaGons	
  for	
  
heroin	
  or	
  fentanyl	
  
20	
  
Within	
  24	
  Hours:	
  	
  
•  Conferences	
  took	
  place	
  with:	
  
– Medical	
  Examiner	
  
•  No	
  increase	
  in	
  the	
  number	
  of	
  overdose	
  cases	
  
•  Heroin	
  cases	
  to	
  be	
  tested	
  for	
  fentanyl	
  
– Syringe	
  Exchange	
  Programs	
  
•  No	
  reported	
  increase	
  in	
  fatal	
  or	
  non	
  fatal	
  overdoses	
  
– NYPD	
  and	
  DEA	
  labs	
  
•  No	
  reported	
  increase	
  heroin	
  samples	
  tested	
  
containing	
  fentanyl	
  
21	
  
Emergency	
  Ac0on	
  Plan	
  Response	
  
•  NYC	
  DOHMH	
  released	
  two	
  advisories	
  
regarding	
  cases	
  of	
  fentanyl-­‐associated	
  
overdoses	
  in	
  Mid-­‐AtlanGc	
  and	
  Northeast	
  
United	
  States:	
  
1.  	
  A	
  Health	
  Alert	
  Network	
  le2er	
  for	
  clinicians	
  	
  
2.  A	
  “Dear	
  Colleague”	
  le2er	
  for	
  program	
  staff	
  
working	
  with	
  drug	
  users	
  
22	
  
PUBLIC	
  SAFETY	
  DATA	
  SOURCES	
  
Michael	
  Clarke,	
  JD,	
  Special	
  Counsel	
  
New	
  York	
  City	
  Mayor’s	
  Office	
  of	
  Criminal	
  JusGce	
  
23	
  
New	
  York	
  County	
  DA	
  Drug	
  Prosecu0ons	
  Involving	
  	
  
Opioid	
  Analgesics	
  	
  
(2012,	
  2013)	
  
Source: New York County District Attorney’s Office
Number	
  of	
  ProsecuGons	
  
Involving	
  Opioid	
  Analgesics	
  
•  From	
  2012	
  to	
  2013,	
  there	
  was	
  an	
  8%	
  increase	
  in	
  prosecuGons	
  by	
  
the	
  New	
  York	
  County	
  DA	
  involving	
  opioid	
  analgesics.	
  
•  In	
  2012	
  and	
  2013,	
  opioid	
  analgesics	
  were	
  involved	
  in	
  approximately	
  
5%	
  of	
  all	
  drug	
  prosecuGons	
  in	
  New	
  York	
  County	
  (excluding	
  
marijuana).	
  
ProsecuGons	
  involving	
  	
  
opioid	
  analgesics:	
  
•  2012=	
  545	
  
•  2013=	
  587	
  
24	
  
Pharmacy	
  Robberies	
  &	
  Burglaries	
  	
  
for	
  Rx	
  Drugs,	
  NYC
(2012	
  &	
  2013)	
  
Burglary	
   Robbery	
   Grand	
  Total	
  
2012	
   2013	
   2012	
   2013	
   	
  2012	
  +	
  2013	
  
Bronx	
   8	
   16	
  	
   4	
   0	
  	
   28	
  
Kings	
   8	
   8	
  	
  =	
   4	
   1	
  	
   21	
  
New	
  York	
   0	
   8	
  	
   5	
   1	
  	
   14	
  
Queens	
   6	
   8	
  	
   2	
   1	
  	
   17	
  
Richmond	
   0	
   1	
  	
   0	
   0	
  	
  =	
   1	
  
Grand	
  Total	
   22	
   41	
   15	
   3	
  	
   81	
  
This	
  database	
  can	
  be	
  used	
  to	
  monitor	
  trends	
  in	
  
real	
  Gme.	
  As	
  of	
  March	
  27,	
  2014	
  there	
  had	
  been	
  
8	
  burglaries	
  and	
  2	
  robberies	
  in	
  NYC	
  in	
  2014.	
  25	
  
 	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  =	
  Burglary	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  =	
  Robbery	
  
New	
  York	
  City	
  
Pharmacy	
  Robberies	
  
and	
  Burglaries	
  
2012	
  -­‐	
  2013	
  
Note:	
  Image	
  created	
  using	
  Google	
  Maps	
  
26	
  
Controlled	
  Prescrip0on	
  Drugs	
  (CPD)	
  Loss/
Thed	
  Reports	
  (DEA	
  106	
  Forms),	
  NYC	
  
•  211	
  incidents	
  reported	
  in	
  2013	
  
– Includes	
  all	
  Schedule	
  II	
  –	
  V	
  controlled	
  substances	
  
– 95	
  incidents	
  of	
  the	
  211	
  in	
  NYC	
  involved	
  opioid	
  
analgesics	
  
•  Approximately	
  173,000	
  total	
  pills	
  lost	
  
– Of	
  the	
  173,000	
  total	
  pills,	
  roughly	
  70%,	
  or	
  
approximately	
  120,000,	
  were	
  opioid	
  analgesic	
  pills	
  
27	
  
Nearly	
  120,000	
  Opioid	
  Analgesic	
  Pills	
  Reported	
  
Lost/Stolen	
  in	
  NYC	
  in	
  2013	
  
Source: Drug Enforcement Administration
Armed	
  Robbery	
  
4%	
  
Customer	
  Theh	
  
2%	
  
Employee	
  
Pilferage	
  
16%	
  
Lost	
  In	
  Transit	
  
6%	
  
Night	
  Break-­‐In	
  
58%	
  
Other	
  
14%	
  
28	
  
Public	
  Safety	
  Data	
  Synthesis	
  
29	
  
•  While	
  there	
  is	
  evidence	
  that	
  drug	
  prosecuGons	
  by	
  the	
  New	
  
York	
  County	
  DA’s	
  Office	
  involving	
  opioid	
  analgesics	
  may	
  be	
  
increasing,	
  they	
  account	
  for	
  a	
  small	
  percentage	
  of	
  total	
  drug	
  
prosecuGons.	
  
•  Pharmacy	
  burglaries	
  and	
  robberies	
  account	
  for	
  small	
  
proporGon	
  of	
  crime	
  in	
  NYC	
  and	
  do	
  not	
  appear	
  to	
  be	
  significant	
  
source	
  of	
  diverted	
  opioid	
  analgesics.	
  
–  Incidents	
  of	
  CPD	
  loss/theh	
  	
  in	
  NYC	
  that	
  were	
  reported	
  to	
  the	
  DEA	
  also	
  
do	
  not	
  appear	
  to	
  be	
  a	
  significant	
  source	
  of	
  diverted	
  opioid	
  analgesics.	
  
The	
  primary	
  category	
  of	
  loss	
  is	
  night	
  break-­‐in.	
  
OPIOID	
  ANALGESICS	
  IN	
  NEW	
  YORK	
  
CITY:	
  A	
  QUALITATIVE	
  STUDY	
  
Alex	
  Harocopos,	
  MS,	
  Senior	
  RxStat	
  Data	
  Analyst	
  
New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  
30	
  
Study	
  Aims	
  
To	
  explore:	
  
-­‐  Circumstances	
  of	
  opioid	
  analgesic	
  (OA)	
  
iniGaGon	
  
-­‐  Trajectory	
  of	
  use	
  (including	
  transiGon	
  to	
  
heroin)	
  
-­‐  Mechanisms	
  of	
  diversion	
  from	
  medical	
  to	
  
non-­‐medical	
  use	
  
31	
  
Data	
  Collec0on	
  
•  In-­‐depth	
  interviews	
  (n=20)	
  with	
  professionals	
  	
  
•  Focus	
  groups	
  (n=5)	
  with	
  individuals	
  who	
  
have	
  experience	
  of	
  OA	
  misuse	
  	
  
•  In-­‐depth	
  interviews	
  (n=49)	
  with	
  current	
  or	
  
recent	
  OA	
  misusers	
  (ongoing)	
  
32	
  
Demographic	
  Characteris0cs	
  
Total	
  
	
  	
  	
  	
  	
  n**	
  
49	
  
Gender	
  
Female	
  
Male	
  
19	
  
30	
  
Age	
  
18	
  –	
  29	
  	
  
30	
  –	
  55	
  	
  
Median	
  age	
  
28	
  
21	
  
28	
  
Race/Ethnicity	
  	
  
Black	
  non-­‐Hispanic	
  
Hispanic	
  
White	
  non-­‐Hispanic	
  
MulG-­‐racial	
  
2	
  
6	
  
39	
  
2	
  
EducaGon	
  
Did	
  not	
  complete	
  high	
  school	
  
Completed	
  high	
  school	
  or	
  GED	
  
Some	
  college	
  (includes	
  trade	
  school)	
  
Completed	
  4	
  year	
  degree	
  or	
  higher	
  
	
  	
  9	
  
13	
  
18	
  
	
  	
  9	
  
Annual	
  household	
  income*	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Under	
  $10,000	
  
$10,000	
  to	
  $24,999	
  
$25,000	
  to	
  $39,999	
  
$40,000	
  to	
  $59,999	
  
$60,000	
  to	
  $99,999	
  
More	
  than	
  $100,000	
  
13	
  
	
  	
  6	
  
	
  	
  8	
  
	
  	
  3	
  
	
  	
  6	
  
	
  	
  7	
  
	
   	
  Profile	
  of	
  OA	
  misusers	
  
*6	
  respondents	
  were	
  unable	
  to	
  esGmate	
  their	
  annual	
  household	
  income	
  **	
  data	
  collecGon	
  is	
  ongoing
Emerging	
  Taxonomy	
  of	
  OA	
  Misusers	
  
1.  18	
  to	
  30	
  years,	
  typically	
  iniGate	
  recreaGonally;	
  
primarily	
  obtain	
  pills	
  through	
  street	
  sources	
  
2.  31	
  years	
  and	
  above,	
  typically	
  iniGate	
  through	
  
medical	
  treatment;	
  primarily	
  obtain	
  pills	
  through	
  
medical	
  sources	
  
3.  Experienced	
  opioid	
  users	
  (i.e.	
  heroin	
  and	
  
methadone);	
  obtain	
  pills	
  through	
  both	
  street	
  and	
  
medical	
  sources	
  
34	
  
Market	
  Dynamics	
  
•  Fractured	
  market	
  driven	
  predominantly	
  by	
  diversion	
  
from	
  prescripGons	
  
•  Varying	
  levels	
  of	
  monitoring	
  by	
  doctors	
  
– ConGnuum	
  ranges	
  from:	
  
negligent	
  →	
  	
  loose	
  	
  →	
  	
  rouGne	
  →	
  judicious	
  
•  Wide	
  variety	
  of	
  diversion	
  schemes	
  idenGfied	
  
– Broad	
  range	
  of	
  criminal	
  complexity	
  
– Visits	
  to	
  mulGple	
  prescribers	
  not	
  cited	
  as	
  a	
  
primary	
  concern	
  
35	
  
Market	
  Dynamics	
  
Diffuse	
  nature	
  of	
  sales	
  networks	
  compounded	
  
by	
  social	
  proximity	
  of	
  buyers	
  and	
  sellers	
  
– PrescripGon	
  opioid	
  sales	
  ohen	
  occur	
  within	
  
closed	
  community	
  networks,	
  not	
  via	
  
community	
  outsiders	
  
36	
  
Market	
  Dynamics	
  
•  Scarcity	
  of	
  OA	
  pills	
  in	
  some	
  networks	
  has	
  led	
  
to	
  an	
  increase	
  in	
  price	
  
•  Heroin	
  is	
  increasingly	
  available	
  in	
  OA-­‐using	
  
networks	
  
•  Selling	
  OAs	
  may	
  fund	
  other	
  drug	
  use	
  (e.g.,	
  
heroin,	
  crack)	
  
37	
  
Risk	
  awareness	
  and	
  service	
  u0liza0on	
  
•  Limited	
  understanding	
  of	
  risk	
  reducGon	
  
– Awareness	
  of	
  risks	
  associated	
  with	
  sharing	
  
needles,	
  but	
  not	
  of	
  sharing	
  paraphernalia	
  
•  Knowledge	
  of	
  overdose	
  prevenGon	
  is	
  ohen	
  
lacking	
  
•  New	
  user	
  cohorts	
  tend	
  to	
  be	
  isolated	
  from	
  
community	
  health	
  services	
  
•  Need	
  for	
  greater	
  acceptance	
  of,	
  and	
  access	
  to	
  
medically-­‐assisted	
  models	
  (i.e.,	
  buprenorphine	
  
and	
  methadone)	
  	
  
38	
  
USING	
  DATA	
  TO	
  INFORM	
  OPIOID	
  POLICIES	
  
AND	
  STRATEGIES	
  IN	
  NEW	
  YORK	
  CITY	
  
Ellenie	
  Tuazon,	
  MPH,	
  Research	
  and	
  Surveillance	
  Analyst	
  
New	
  York	
  City	
  Department	
  of	
  Health	
  and	
  Mental	
  Hygiene	
  
39	
  
Data	
  Driven	
  Ini0a0ves	
  
Reduce	
  
Overdose	
  
Deaths	
  
MME	
  
Calculator	
  
Emergency	
  
AcGon	
  
Plan	
  
NYPD	
  
Naloxone	
  
Project	
  
Staten	
  
Island	
  
Detailing	
  
ED	
  
Guidelines	
  
Overdose	
  
PrevenGon	
  
Programs	
  
Opioid	
  
Prescribing	
  
Guidelines	
  
Media	
  
Campaign	
  
Media	
  
Campaign	
  
MME	
  
Calculator	
  
Staten	
  
Island	
  
Detailing	
  
NYPD	
  
Naloxone	
  
Project	
  
Overdose	
  
PrevenGon	
  
Programs	
  
ED	
  
Guidelines	
  
Opioid	
  
Prescribing	
  
Guidelines	
  
Emergency	
  
AcGon	
  
Plan	
  
DHS	
  
Naloxone	
  
Project	
  
HHC	
  	
  
Prescribing	
  
HHC	
  	
  
Prescribing	
  
DHS	
  
Naloxone	
  
Project	
  
40	
  
Opioid	
  Prescribing	
  Guidelines	
  
•  Less	
  ohen:	
  avoid	
  prescribing	
  opioids	
  for	
  
chronic	
  non-­‐cancer,	
  non-­‐end-­‐of-­‐life	
  pain	
  
  e.g.,	
  low	
  back	
  pain,	
  arthriGs,	
  headache,	
  
fibromyalgia	
  
•  Shorter	
  duraGon:	
  when	
  opioids	
  are	
  
warranted	
  for	
  acute	
  pain,	
  3-­‐day	
  supply	
  
usually	
  sufficient	
  
•  Lower	
  doses:	
  if	
  dosing	
  reaches	
  100	
  
Morphine	
  Milligram	
  Equivalents	
  (MME)	
  ,	
  
reassess	
  and	
  reconsider	
  other	
  
approaches	
  to	
  pain	
  management	
  
•  Avoid	
  whenever	
  possible	
  prescribing	
  
opioids	
  in	
  paGents	
  taking	
  
benzodiazepines	
  
CitaGon:	
  Paone	
  D,	
  Dowell	
  D,	
  Heller	
  D.	
  PrevenGng	
  misuse	
  of	
  prescripGon	
  opioid	
  drugs.	
  City	
  Health	
  InformaGon.	
  2011;	
  30(4):	
  23-­‐30	
  
New	
  York	
  City	
  Opioid	
  Treatment	
  Guidelines,	
  Clinical	
  	
  Advisors:	
  Nancy	
  Chang,	
  MD;	
  Marc	
  N.	
  Gourevitch,	
  MD,	
  MPH;	
  Mark	
  P.	
  Jarre2,	
  MD,	
  
MBA;	
  Andrew	
  Kolodny,	
  MD;	
  Lewis	
  Nelson,	
  MD;	
  Russell	
  K.	
  Portenoy,	
  MD;	
  Jack	
  Resnick,	
  MD;	
  Stephen	
  Ross,	
  MD;	
  Joanna	
  L.	
  Starrels,	
  MD,	
  
MS;	
  David	
  L.	
  Stevens,	
  MD;	
  Anne	
  Marie	
  SGlwell,	
  MD;	
  Theodore	
  Strange;	
  MD,	
  FACP;	
  Homer	
  Venters,	
  MD,	
  MS	
  	
  
41	
  
New	
  York	
  City	
  Emergency	
  Department	
  Discharge	
  Opioid	
  Prescribing	
  Guidelines	
  Clinical	
  Advisory	
  Group:	
  Jason	
  Chu,	
  
MD,	
  Brenna	
  Farmer,	
  MD,	
  Beth	
  Y.	
  Ginsburg,	
  MD,	
  Stephanie	
  H.	
  Hernandez,	
  MD,	
  James	
  F.	
  Kenny,	
  MD,	
  MBA,	
  FACEP,	
  Nima	
  
Majlesi,	
  DO,	
  Ruben	
  Olmedo,	
  MD,	
  Dean	
  Olsen,	
  DO,	
  James	
  G.	
  Ryan,	
  MD,	
  Bonnie	
  Simmons,	
  DO,	
  Mark	
  Su,	
  MD,	
  Michael	
  
Touger,	
  MD,	
  Sage	
  W.	
  Wiener,	
  MD.	
  
Emergency	
  Department	
  Guidelines	
  
Released	
  
January,	
  2013	
  
Adopted	
  by	
  38	
  
NYC	
  emergency	
  
departments	
  
42	
  
NYC	
  Health	
  and	
  Hospitals	
  
Corpora0on	
  (HHC)	
  
•  All	
  11	
  HHC	
  emergency	
  departments	
  use	
  NYC	
  
Emergency	
  Department	
  Discharge	
  Prescribing	
  
Guidelines	
  
•  Built	
  systems	
  to	
  evaluate	
  ED	
  prescribing	
  trends	
  
43	
  
Staten	
  Island	
  Public	
  Health	
  
“Detailing”	
  Campaign	
  
•  1-­‐on-­‐1	
  “detailing”	
  visits	
  from	
  
Health	
  Department	
  representaGves	
  
•  Deliver	
  key	
  prescribing	
  
recommendaGons,	
  clinical	
  tools,	
  
paGent	
  educaGon	
  materials	
  
•  ~1,000	
  Staten	
  Island	
  physicians,	
  
nurse	
  pracGGoners,	
  physicians	
  
assistants	
  
•  June–August	
  2013	
  
44	
  
45	
  
Morphine	
  Milligram	
  Equivalent	
  (MME)	
  
Calculator	
  
•  A	
  tool	
  to	
  calculate	
  total	
  MME	
  per	
  day	
  
•  Gives	
  alert	
  for	
  dosages	
  >100	
  MME	
  
•  Quick	
  and	
  easy	
  to	
  use	
  
•  Web-­‐based	
  applicaGon	
  
–  Search	
  for	
  “NYC	
  MME	
  Calculator”	
  
h2p://www.nyc.gov/html/doh/html/mental/MME.html	
  
•  Smartphone	
  app	
  
46	
  
47	
  
Media	
  Campaigns	
  
•  Campaign	
  One:	
  	
  
–  Goal:	
  Increase	
  awareness	
  of	
  risk	
  of	
  opioid	
  analgesic	
  overdose	
  
–  Ran	
  twice	
  (2012,	
  2013)	
  
•  Campaign	
  Two:	
  	
  
–  Goal:	
  Reduce	
  sGgma	
  and	
  raise	
  awareness	
  of	
  opioid	
  analgesic	
  
misuse	
  
–  2	
  tesGmonials	
  
•  Mom	
  lost	
  son	
  to	
  opioid	
  analgesic	
  overdose	
  
•  NYC	
  resident	
  	
  in	
  recovery	
  
–  Ran	
  2013	
  and	
  2014	
  
48	
  
Available	
  at:	
  hWp://www.youtube.com/watch?v=ozJ6W69rOuU&feature=youtube	
  
49	
  
Overdose	
  (OD)	
  Preven0on:	
  Naloxone	
  
50	
  
In	
  New	
  York	
  State,	
  trained	
  laypersons	
  can	
  
legally	
  administer	
  naloxone	
  for	
  OD	
  preven0on	
  
•  Per	
  NYS	
  Public	
  Health	
  Law	
  “Opioid	
  Overdose	
  
PrevenGon	
  Program”	
  
– EffecGve	
  April	
  1,	
  2006	
  
•  Laypersons	
  can	
  become	
  Trained	
  Overdose	
  
Responders	
  
•  Trained	
  Overdose	
  Responders	
  can	
  legally	
  carry	
  and	
  
use	
  naloxone	
  
51	
  
Intranasal	
  Naloxone	
  Distribu0on	
  in	
  NYC	
  
Since	
  2010	
  
Other	
  	
  
(e.g.,	
  shelters,	
  
hospitals)	
  
14%	
  
Syringe	
  
Exchange	
  
Programs	
  
	
  73%	
  
>25,000	
  kits	
  distributed	
  
>200	
  reversals	
  reported	
  
	
  	
  	
  (underrepor0ng)	
  
Drug	
  Treatment	
  
Programs	
  13%	
  
52	
  
NYC	
  Department	
  of	
  Homeless	
  
Services	
  (DHS)	
  
More	
  than	
  half	
  DHS	
  Peace	
  Officers	
  are	
  trained	
  
and	
  carry	
  naloxone	
  in	
  all	
  city	
  shelters	
  
53	
  
NYPD	
  Naloxone	
  Project	
  
•  All	
  NYPD	
  officers	
  in	
  the	
  120	
  precinct	
  on	
  Staten	
  
Island	
  (approximately	
  180)	
  have	
  been	
  trained	
  
to	
  carry	
  and	
  dispense	
  naloxone	
  
•  Reported	
  reversals	
  
54	
  
New	
  York	
  State	
  Good	
  Samaritan	
  Law	
  
55	
  
Summary	
  
•  Opioid	
  misuse	
  and	
  its	
  health	
  consequences	
  
consGtute	
  a	
  public	
  health	
  crisis	
  
•  MulG-­‐pronged	
  approaches	
  are	
  needed	
  
•  Changing	
  prescribing	
  pa2erns	
  is	
  key	
  
•  Raising	
  public	
  awareness	
  
•  MulG-­‐agency	
  use	
  of	
  naloxone	
  
•  Ensuring	
  access	
  to	
  effecGve	
  treatment	
  
•  This	
  problem	
  is	
  preventable!	
  
56	
  
Conclusion	
  
•  RxStat	
  is	
  a	
  collaboraGon	
  between	
  NYC	
  public	
  
health	
  and	
  public	
  safety	
  toward	
  one	
  unifying	
  
goal:	
  	
  Reduce	
  overdose	
  deaths	
  in	
  NYC	
  
•  Timely/real-­‐Gme	
  data	
  informs	
  comprehensive,	
  
mulG-­‐pronged	
  responses	
  to	
  opioid	
  analgesic	
  
misuse	
  
57	
  

Contenu connexe

Tendances

Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderOPUNITE
 
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderRx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderOPUNITE
 
Rx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritoxRx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritoxOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickOPUNITE
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanOPUNITE
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezOPUNITE
 
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellRx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellOPUNITE
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveOPUNITE
 
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHScOpioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHScUniversity of Michigan Injury Center
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisOPUNITE
 
Rx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisRx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 

Tendances (20)

Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexanderRx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
Rx16 adv tues_1115_1_seymourhsu_2baird_3cochran_4hartung_5alexander
 
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderRx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
 
Rx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritoxRx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritox
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonaldRx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
Rx16 treat tues_330_1_mcneely_2d_onofrio_3macdonald
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonickRx16 treat tues_200_1_jarvis_2fiscella_3balonick
Rx16 treat tues_200_1_jarvis_2fiscella_3balonick
 
Rx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gormanRx16 adv wed_1230_1_thau_2gorman
Rx16 adv wed_1230_1_thau_2gorman
 
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosalesRx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
Rx16 presummit mat-mon_200_1_bisaga_2walls_3coupland_4dupont_5garcia-rosales
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendezRx16 len tues_200_1_beshear_2ohr-menendez
Rx16 len tues_200_1_beshear_2ohr-menendez
 
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbellRx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
Rx15 treat tues_330_1_manns_2weiss_3ghitza_4campbell
 
Rx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manloveRx16 advocacy wed_200_1_mendell_2manlove
Rx16 advocacy wed_200_1_mendell_2manlove
 
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHScOpioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
 
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harrisRx16 vs ama_tues_800_harris
Rx16 vs ama_tues_800_harris
 
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
 
Rx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willisRx16 heroin tues_200_1_allen-harocopos_2willis
Rx16 heroin tues_200_1_allen-harocopos_2willis
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 

Similaire à Wed vs rx stat

Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonOPUNITE
 
Henry Spiller edited
Henry Spiller editedHenry Spiller edited
Henry Spiller editedOPUNITE
 
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance AbuseHawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance AbuseClifton M. Hasegawa & Associates, LLC
 
Wed vs ondcp labelle
Wed vs ondcp labelleWed vs ondcp labelle
Wed vs ondcp labelleOPUNITE
 
New York SEPs State Fact Sheet_4.19.13
New York SEPs State Fact Sheet_4.19.13New York SEPs State Fact Sheet_4.19.13
New York SEPs State Fact Sheet_4.19.13Mary Beth Levin
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0satoriwatersfl
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalOPUNITE
 
Opioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureOpioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureCitiusTech
 
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...KemalAbdela2
 
Barbara Krantz
Barbara KrantzBarbara Krantz
Barbara KrantzOPUNITE
 
Ea 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeEa 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeOPUNITE
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday asthoOPUNITE
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.pptShirazKhokhar1
 
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...University of Michigan Injury Center
 
Fred Brason
Fred BrasonFred Brason
Fred BrasonOPUNITE
 

Similaire à Wed vs rx stat (20)

Survey 2009drugod
Survey 2009drugodSurvey 2009drugod
Survey 2009drugod
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
 
Henry Spiller edited
Henry Spiller editedHenry Spiller edited
Henry Spiller edited
 
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance AbuseHawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
 
Newyorkcity2014
Newyorkcity2014Newyorkcity2014
Newyorkcity2014
 
Wed vs ondcp labelle
Wed vs ondcp labelleWed vs ondcp labelle
Wed vs ondcp labelle
 
New York SEPs State Fact Sheet_4.19.13
New York SEPs State Fact Sheet_4.19.13New York SEPs State Fact Sheet_4.19.13
New York SEPs State Fact Sheet_4.19.13
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
ERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose PatientsERs Face the Problem of Multiple Drugs in Overdose Patients
ERs Face the Problem of Multiple Drugs in Overdose Patients
 
Opioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and FutureOpioid Epidemic - Causes, Impact and Future
Opioid Epidemic - Causes, Impact and Future
 
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
Evidence-Based-Substance-Use-Disorder-Treatment---Use-of-Medication-Assisted-...
 
Barbara Krantz
Barbara KrantzBarbara Krantz
Barbara Krantz
 
Ea 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heekeEa 1 bullard cawhtorne_ taylorpowell_heeke
Ea 1 bullard cawhtorne_ taylorpowell_heeke
 
Substance Abuse and the ED
Substance Abuse and the EDSubstance Abuse and the ED
Substance Abuse and the ED
 
aidslinedec13
aidslinedec13aidslinedec13
aidslinedec13
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
 
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
 
Fred Brason
Fred BrasonFred Brason
Fred Brason
 

Plus de OPUNITE

Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerOPUNITE
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyOPUNITE
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorOPUNITE
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200OPUNITE
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenOPUNITE
 

Plus de OPUNITE (20)

Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copyWeb only rx16 len wed_200_1_augustine_2napier_3darr - copy
Web only rx16 len wed_200_1_augustine_2napier_3darr - copy
 
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylorRx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
Rx16 heroin wed_200_1_parker-daley_2guarino-luongo_3taylor
 
Rx16 federal visionsession_200
Rx16 federal visionsession_200Rx16 federal visionsession_200
Rx16 federal visionsession_200
 
Rx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2greenRx16 clinical wed_200_1_hall_2green
Rx16 clinical wed_200_1_hall_2green
 

Dernier

Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Dipal Arora
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableDipal Arora
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiAlinaDevecerski
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...Arohi Goyal
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomdiscovermytutordmt
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...hotbabesbook
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...astropune
 
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...tanya dube
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...chandars293
 
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 9332606886  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 9332606886  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...narwatsonia7
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...Taniya Sharma
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...perfect solution
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
 

Dernier (20)

Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
Best Rate (Guwahati ) Call Girls Guwahati ⟟ 8617370543 ⟟ High Class Call Girl...
 
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
💎VVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
 
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Gwalior Just Call 8617370543 Top Class Call Girl Service Available
 
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI 🔝9711199012 ☪ 24/7 Call Girls Delhi
 
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ooty Just Call 9907093804 Top Class Call Girl Service Available
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
 
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel roomLucknow Call girls - 8800925952 - 24x7 service with hotel room
Lucknow Call girls - 8800925952 - 24x7 service with hotel room
 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
♛VVIP Hyderabad Call Girls Chintalkunta🖕7001035870🖕Riya Kappor Top Call Girl ...
 
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 9907093804 Top Class Call Girl Service Available
 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...Top Rated  Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
Top Rated Hyderabad Call Girls Erragadda ⟟ 6297143586 ⟟ Call Me For Genuine ...
 
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 9907093804 Top Class Call Girl Service Available
 
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 9332606886  Meetin With Bangalore Esc...Bangalore Call Girls Nelamangala Number 9332606886  Meetin With Bangalore Esc...
Bangalore Call Girls Nelamangala Number 9332606886 Meetin With Bangalore Esc...
 
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
(👑VVIP ISHAAN ) Russian Call Girls Service Navi Mumbai🖕9920874524🖕Independent...
 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
 
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Siliguri Just Call 9907093804 Top Class Call Girl Service Available
 

Wed vs rx stat

  • 1. NYC  RxStat:  A  Collabora0ve   Approach  to  Surveillance  of   Prescrip0on  Drug  Misuse  and   Associated    Consequences   April  23,  2014   Atlanta  Marrio2  Marquis   1  
  • 2. Learning  Objec0ves   1.  Describe  how  public  health/public  safety   partnership  informs  City’s  response  to  opioid   analgesic  misuse   2.  Real-­‐Gme  data  in  acGon:  Use  Gmely  data  to   shape  response  to  public  health  events   3.  Data-­‐driven  policy:  Use  data  to  inform  City’s   opioid-­‐related  policies  and  strategies   2  
  • 3. Disclosure  Statement   Steven  Newmark,  Michelle  Nolan,  Michael   Clarke,  Alexandra  Harocopos  and  Ellenie  Tuazon   have  no  financial  relaGonships  with  proprietary   enGGes  that  produce  health  care  goods  and   services   3  
  • 4. Outline   •  RxStat  Overview   (Steven  Newmark,  NYC  Office  of  the  Mayor)   •  Public  Health  Data  Sources   (Michelle  Nolan,  NYC  Dept.  of  Health  and  Mental  Hygiene)   •  Public  Safety  Data  Sources   (Michael  Clarke,  NYC  Mayor’s  Office  of  Criminal  JusFce)   •  Opioid  Analgesics  in  New  York  City:  A  Qualita0ve  Study   (Alexandra  Harocopos,  NYC  Dept.  of  Health  and  Mental  Hygiene)   •  Data  Driven  Opioid  Policies  and  Strategies  in  New  York  City     (Ellenie  Tuazon,  NYC  Dept.  of  Health  and  Mental  Hygiene)   4  
  • 5. RXSTAT  OVERVIEW   Steven  Newmark,  JD/MPA,  Sr.  Policy  Advisor  &  Counsel  to  the  Deputy   Mayor  for  Health  and  Human  Services   New  York  City  Office  of  the  Mayor   5  
  • 6. Opioid  Analgesics  Are  a  Public  Health  Crisis  in     New  York  City   *Paone D, Bradley O’Brien D, Shah S, Heller D. Opioid analgesics in New York City: misuse, morbidity and mortality update. Epi Data Brief. April 2011. Available at http://www.nyc.gov/html/doh/downloads/pdf/epi/epi-data-brief.pdf . 6  
  • 7. RxStat:  Central  Focus  and  Unifying  Goal   Reduce   Overdose   Deaths   7  
  • 8. RxStat:  Four  Core  Principles   •  Timely,  accurate  analysis  of  drug  misuse   indicators  from  mulGple  sources  (e.g.,  mortality,   EDs,  PMP,  drug  treatment,  law  enforcement,  etc.)   •  Develop  strategies  based  on  analysis  of  exisGng   and  newly  available  data   •  Rapid  deployment  of  public  health  and  public   safety  resources  to  high  priority  areas   •  Rigorous  follow-­‐up  to  ensure  strategies  are   effecGve   8  
  • 9. RxStat   •  Public  health  &  public  safety  collaboraGon   – Housed  at  NYC  Department  of  Health  &  Mental   Hygiene  (DOHMH)  leverages  experGse  and   infrastructure     •  “Real-­‐Gme”  (enhanced)  surveillance   •  ParGcipants  and  stakeholders  at  city,  state,   and  federal  organizaGons     •  Monthly  RxStat  Data  MeeGngs   9  
  • 10. Layering  and  Repor0ng  Data   Reduce   Overdose   Deaths   10  
  • 11. Data  Sources   Reduce   Overdose   Deaths   PMP   Data   Treatment     Admissions   Poison   Control   Drug   ProsecuGons   HospitalizaGons   Jail   Data   Mortality   DEA   ARCOS   Pharmacy   Crime   Price/Purity   QualitaGve   Research   Medicaid   Fraud  Data   Syndromic   QualitaGve   Research   Mortality   Pharmacy   Crime   DEA   ARCOS   Drug   ProsecuGons   11  
  • 12. PUBLIC  HEALTH  DATA  SOURCES   Michelle  Nolan,  MPH,  RxStat  Data  Analyst   New  York  City  Department  of  Health  and  Mental  Hygiene   12  
  • 13. Outline   •  Describe  opioid  analgesic  use  and  misuse  in   New  York  City   •  Discuss  an  example  of  how  real-­‐Gme  data  was   used  to  inform  a  public  health  response   13  
  • 14. Opioid  Analgesic  Use  and  Misuse  in  NYC   •  In  2012,  700,000  New  Yorkers  filled  more  than   2  million  opioid  analgesic  prescripGons     •  In  2010-­‐2011,  4%  (162,000)  of  New  Yorkers   aged  12  and  older  reported  past  year  opioid   analgesic  misuse   •  In  2011,  the  rate  of  emergency  department   visits  a2ributed  to  opioid  analgesic  misuse/ abuse  was  141.3/100,000  New  Yorkers   14  
  • 15. Opioids  Were  Involved  In  73%  of  Overdose   Deaths  in  NYC   0 100 200 300 400 500 600 700 800 900 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Number Year of Death Total Opioids Heroin Opioid Analgesics NOTE:  Drugs  not  mutually  exclusive   Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene 2000-2012 15  
  • 16. 59 66 78 81 93 130 152 131 137 151 173 220 201 0.9 1 1.3 1.3 1.5 2 2.4 2 2.1 2.3 2.6 3.3 3.0 0 0.5 1 1.5 2 2.5 3 3.5 0 50 100 150 200 250 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Age-adjustedrateper100,000 Number Number of unintentional opioid analgesic poisoning deaths Age-adjusted rate per 100,000 Opioid  Analgesic  Overdose  Deaths  Increased  233%  from   2000  to  2012,  NYC   Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene 2000-2012 16  
  • 17. 373 416 400 438 358 379 388 301 317 288 209 284 382 5.9 6.3 6.3 6.9 5.7 5.9 6.1 4.7 4.9 4.4 3.1 4.2 5.7 0 1 2 3 4 5 6 7 8 0 50 100 150 200 250 300 350 400 450 500 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Age-adjustedrateper100,000 Number Number of unintentional heroin poisoning deaths Age-adjusted rate per 100,000 Heroin  Overdose  Deaths  Increased  84%  from     2010  to  2012,  NYC   Source: New York City Office of the Chief Medical Examiner & New York City Department of Health and Mental Hygiene 2000-2012 17  
  • 18. What  About  Heroin?   •  Increases  in  heroin-­‐related  overdose  deaths  beginning   in  2011  preceded  decreases  in  opioid  analgesic-­‐related   overdose  deaths  in  2012     •  Similarly  the  increase  in  heroin  deaths  in  New  York  City   aher  2010  was  not  preceded  by  a  decrease  in  the   prescribing  of  opioid  analgesics,  suggesGng  that  the   heroin  overdose  increase  occurred  independent  of  any   changes  in  prescripGon  opioid  availability   18  
  • 19. Emergency  Ac0on  Plan   •  Early  January,  2014:  Mid-­‐AtlanGc  and   Northeast  states  reported  an  increase  in  the   number  of  overdoses  related  to  heroin   containing  fentanyl   •  February,  2014:  Mass  media  coverage  of   heroin  following  the  death  of  a  public  figure  in   New  York  City   19  
  • 20. Within  24  Hours:     •  NYC  DOHMH  data  review  of:   – Syndromic  surveillance   •  No  detectable  increase  in  the  number  of   emergency  department  visits  for  overdose   – Poison  Control  Data   •  No  increase  in  the  number  of  consultaGons  for   heroin  or  fentanyl   20  
  • 21. Within  24  Hours:     •  Conferences  took  place  with:   – Medical  Examiner   •  No  increase  in  the  number  of  overdose  cases   •  Heroin  cases  to  be  tested  for  fentanyl   – Syringe  Exchange  Programs   •  No  reported  increase  in  fatal  or  non  fatal  overdoses   – NYPD  and  DEA  labs   •  No  reported  increase  heroin  samples  tested   containing  fentanyl   21  
  • 22. Emergency  Ac0on  Plan  Response   •  NYC  DOHMH  released  two  advisories   regarding  cases  of  fentanyl-­‐associated   overdoses  in  Mid-­‐AtlanGc  and  Northeast   United  States:   1.   A  Health  Alert  Network  le2er  for  clinicians     2.  A  “Dear  Colleague”  le2er  for  program  staff   working  with  drug  users   22  
  • 23. PUBLIC  SAFETY  DATA  SOURCES   Michael  Clarke,  JD,  Special  Counsel   New  York  City  Mayor’s  Office  of  Criminal  JusGce   23  
  • 24. New  York  County  DA  Drug  Prosecu0ons  Involving     Opioid  Analgesics     (2012,  2013)   Source: New York County District Attorney’s Office Number  of  ProsecuGons   Involving  Opioid  Analgesics   •  From  2012  to  2013,  there  was  an  8%  increase  in  prosecuGons  by   the  New  York  County  DA  involving  opioid  analgesics.   •  In  2012  and  2013,  opioid  analgesics  were  involved  in  approximately   5%  of  all  drug  prosecuGons  in  New  York  County  (excluding   marijuana).   ProsecuGons  involving     opioid  analgesics:   •  2012=  545   •  2013=  587   24  
  • 25. Pharmacy  Robberies  &  Burglaries     for  Rx  Drugs,  NYC (2012  &  2013)   Burglary   Robbery   Grand  Total   2012   2013   2012   2013    2012  +  2013   Bronx   8   16     4   0     28   Kings   8   8    =   4   1     21   New  York   0   8     5   1     14   Queens   6   8     2   1     17   Richmond   0   1     0   0    =   1   Grand  Total   22   41   15   3     81   This  database  can  be  used  to  monitor  trends  in   real  Gme.  As  of  March  27,  2014  there  had  been   8  burglaries  and  2  robberies  in  NYC  in  2014.  25  
  • 26.                      =  Burglary                        =  Robbery   New  York  City   Pharmacy  Robberies   and  Burglaries   2012  -­‐  2013   Note:  Image  created  using  Google  Maps   26  
  • 27. Controlled  Prescrip0on  Drugs  (CPD)  Loss/ Thed  Reports  (DEA  106  Forms),  NYC   •  211  incidents  reported  in  2013   – Includes  all  Schedule  II  –  V  controlled  substances   – 95  incidents  of  the  211  in  NYC  involved  opioid   analgesics   •  Approximately  173,000  total  pills  lost   – Of  the  173,000  total  pills,  roughly  70%,  or   approximately  120,000,  were  opioid  analgesic  pills   27  
  • 28. Nearly  120,000  Opioid  Analgesic  Pills  Reported   Lost/Stolen  in  NYC  in  2013   Source: Drug Enforcement Administration Armed  Robbery   4%   Customer  Theh   2%   Employee   Pilferage   16%   Lost  In  Transit   6%   Night  Break-­‐In   58%   Other   14%   28  
  • 29. Public  Safety  Data  Synthesis   29   •  While  there  is  evidence  that  drug  prosecuGons  by  the  New   York  County  DA’s  Office  involving  opioid  analgesics  may  be   increasing,  they  account  for  a  small  percentage  of  total  drug   prosecuGons.   •  Pharmacy  burglaries  and  robberies  account  for  small   proporGon  of  crime  in  NYC  and  do  not  appear  to  be  significant   source  of  diverted  opioid  analgesics.   –  Incidents  of  CPD  loss/theh    in  NYC  that  were  reported  to  the  DEA  also   do  not  appear  to  be  a  significant  source  of  diverted  opioid  analgesics.   The  primary  category  of  loss  is  night  break-­‐in.  
  • 30. OPIOID  ANALGESICS  IN  NEW  YORK   CITY:  A  QUALITATIVE  STUDY   Alex  Harocopos,  MS,  Senior  RxStat  Data  Analyst   New  York  City  Department  of  Health  and  Mental  Hygiene   30  
  • 31. Study  Aims   To  explore:   -­‐  Circumstances  of  opioid  analgesic  (OA)   iniGaGon   -­‐  Trajectory  of  use  (including  transiGon  to   heroin)   -­‐  Mechanisms  of  diversion  from  medical  to   non-­‐medical  use   31  
  • 32. Data  Collec0on   •  In-­‐depth  interviews  (n=20)  with  professionals     •  Focus  groups  (n=5)  with  individuals  who   have  experience  of  OA  misuse     •  In-­‐depth  interviews  (n=49)  with  current  or   recent  OA  misusers  (ongoing)   32  
  • 33. Demographic  Characteris0cs   Total            n**   49   Gender   Female   Male   19   30   Age   18  –  29     30  –  55     Median  age   28   21   28   Race/Ethnicity     Black  non-­‐Hispanic   Hispanic   White  non-­‐Hispanic   MulG-­‐racial   2   6   39   2   EducaGon   Did  not  complete  high  school   Completed  high  school  or  GED   Some  college  (includes  trade  school)   Completed  4  year  degree  or  higher      9   13   18      9   Annual  household  income*                          Under  $10,000   $10,000  to  $24,999   $25,000  to  $39,999   $40,000  to  $59,999   $60,000  to  $99,999   More  than  $100,000   13      6      8      3      6      7      Profile  of  OA  misusers   *6  respondents  were  unable  to  esGmate  their  annual  household  income  **  data  collecGon  is  ongoing
  • 34. Emerging  Taxonomy  of  OA  Misusers   1.  18  to  30  years,  typically  iniGate  recreaGonally;   primarily  obtain  pills  through  street  sources   2.  31  years  and  above,  typically  iniGate  through   medical  treatment;  primarily  obtain  pills  through   medical  sources   3.  Experienced  opioid  users  (i.e.  heroin  and   methadone);  obtain  pills  through  both  street  and   medical  sources   34  
  • 35. Market  Dynamics   •  Fractured  market  driven  predominantly  by  diversion   from  prescripGons   •  Varying  levels  of  monitoring  by  doctors   – ConGnuum  ranges  from:   negligent  →    loose    →    rouGne  →  judicious   •  Wide  variety  of  diversion  schemes  idenGfied   – Broad  range  of  criminal  complexity   – Visits  to  mulGple  prescribers  not  cited  as  a   primary  concern   35  
  • 36. Market  Dynamics   Diffuse  nature  of  sales  networks  compounded   by  social  proximity  of  buyers  and  sellers   – PrescripGon  opioid  sales  ohen  occur  within   closed  community  networks,  not  via   community  outsiders   36  
  • 37. Market  Dynamics   •  Scarcity  of  OA  pills  in  some  networks  has  led   to  an  increase  in  price   •  Heroin  is  increasingly  available  in  OA-­‐using   networks   •  Selling  OAs  may  fund  other  drug  use  (e.g.,   heroin,  crack)   37  
  • 38. Risk  awareness  and  service  u0liza0on   •  Limited  understanding  of  risk  reducGon   – Awareness  of  risks  associated  with  sharing   needles,  but  not  of  sharing  paraphernalia   •  Knowledge  of  overdose  prevenGon  is  ohen   lacking   •  New  user  cohorts  tend  to  be  isolated  from   community  health  services   •  Need  for  greater  acceptance  of,  and  access  to   medically-­‐assisted  models  (i.e.,  buprenorphine   and  methadone)     38  
  • 39. USING  DATA  TO  INFORM  OPIOID  POLICIES   AND  STRATEGIES  IN  NEW  YORK  CITY   Ellenie  Tuazon,  MPH,  Research  and  Surveillance  Analyst   New  York  City  Department  of  Health  and  Mental  Hygiene   39  
  • 40. Data  Driven  Ini0a0ves   Reduce   Overdose   Deaths   MME   Calculator   Emergency   AcGon   Plan   NYPD   Naloxone   Project   Staten   Island   Detailing   ED   Guidelines   Overdose   PrevenGon   Programs   Opioid   Prescribing   Guidelines   Media   Campaign   Media   Campaign   MME   Calculator   Staten   Island   Detailing   NYPD   Naloxone   Project   Overdose   PrevenGon   Programs   ED   Guidelines   Opioid   Prescribing   Guidelines   Emergency   AcGon   Plan   DHS   Naloxone   Project   HHC     Prescribing   HHC     Prescribing   DHS   Naloxone   Project   40  
  • 41. Opioid  Prescribing  Guidelines   •  Less  ohen:  avoid  prescribing  opioids  for   chronic  non-­‐cancer,  non-­‐end-­‐of-­‐life  pain     e.g.,  low  back  pain,  arthriGs,  headache,   fibromyalgia   •  Shorter  duraGon:  when  opioids  are   warranted  for  acute  pain,  3-­‐day  supply   usually  sufficient   •  Lower  doses:  if  dosing  reaches  100   Morphine  Milligram  Equivalents  (MME)  ,   reassess  and  reconsider  other   approaches  to  pain  management   •  Avoid  whenever  possible  prescribing   opioids  in  paGents  taking   benzodiazepines   CitaGon:  Paone  D,  Dowell  D,  Heller  D.  PrevenGng  misuse  of  prescripGon  opioid  drugs.  City  Health  InformaGon.  2011;  30(4):  23-­‐30   New  York  City  Opioid  Treatment  Guidelines,  Clinical    Advisors:  Nancy  Chang,  MD;  Marc  N.  Gourevitch,  MD,  MPH;  Mark  P.  Jarre2,  MD,   MBA;  Andrew  Kolodny,  MD;  Lewis  Nelson,  MD;  Russell  K.  Portenoy,  MD;  Jack  Resnick,  MD;  Stephen  Ross,  MD;  Joanna  L.  Starrels,  MD,   MS;  David  L.  Stevens,  MD;  Anne  Marie  SGlwell,  MD;  Theodore  Strange;  MD,  FACP;  Homer  Venters,  MD,  MS     41  
  • 42. New  York  City  Emergency  Department  Discharge  Opioid  Prescribing  Guidelines  Clinical  Advisory  Group:  Jason  Chu,   MD,  Brenna  Farmer,  MD,  Beth  Y.  Ginsburg,  MD,  Stephanie  H.  Hernandez,  MD,  James  F.  Kenny,  MD,  MBA,  FACEP,  Nima   Majlesi,  DO,  Ruben  Olmedo,  MD,  Dean  Olsen,  DO,  James  G.  Ryan,  MD,  Bonnie  Simmons,  DO,  Mark  Su,  MD,  Michael   Touger,  MD,  Sage  W.  Wiener,  MD.   Emergency  Department  Guidelines   Released   January,  2013   Adopted  by  38   NYC  emergency   departments   42  
  • 43. NYC  Health  and  Hospitals   Corpora0on  (HHC)   •  All  11  HHC  emergency  departments  use  NYC   Emergency  Department  Discharge  Prescribing   Guidelines   •  Built  systems  to  evaluate  ED  prescribing  trends   43  
  • 44. Staten  Island  Public  Health   “Detailing”  Campaign   •  1-­‐on-­‐1  “detailing”  visits  from   Health  Department  representaGves   •  Deliver  key  prescribing   recommendaGons,  clinical  tools,   paGent  educaGon  materials   •  ~1,000  Staten  Island  physicians,   nurse  pracGGoners,  physicians   assistants   •  June–August  2013   44  
  • 45. 45  
  • 46. Morphine  Milligram  Equivalent  (MME)   Calculator   •  A  tool  to  calculate  total  MME  per  day   •  Gives  alert  for  dosages  >100  MME   •  Quick  and  easy  to  use   •  Web-­‐based  applicaGon   –  Search  for  “NYC  MME  Calculator”   h2p://www.nyc.gov/html/doh/html/mental/MME.html   •  Smartphone  app   46  
  • 47. 47  
  • 48. Media  Campaigns   •  Campaign  One:     –  Goal:  Increase  awareness  of  risk  of  opioid  analgesic  overdose   –  Ran  twice  (2012,  2013)   •  Campaign  Two:     –  Goal:  Reduce  sGgma  and  raise  awareness  of  opioid  analgesic   misuse   –  2  tesGmonials   •  Mom  lost  son  to  opioid  analgesic  overdose   •  NYC  resident    in  recovery   –  Ran  2013  and  2014   48  
  • 50. Overdose  (OD)  Preven0on:  Naloxone   50  
  • 51. In  New  York  State,  trained  laypersons  can   legally  administer  naloxone  for  OD  preven0on   •  Per  NYS  Public  Health  Law  “Opioid  Overdose   PrevenGon  Program”   – EffecGve  April  1,  2006   •  Laypersons  can  become  Trained  Overdose   Responders   •  Trained  Overdose  Responders  can  legally  carry  and   use  naloxone   51  
  • 52. Intranasal  Naloxone  Distribu0on  in  NYC   Since  2010   Other     (e.g.,  shelters,   hospitals)   14%   Syringe   Exchange   Programs    73%   >25,000  kits  distributed   >200  reversals  reported        (underrepor0ng)   Drug  Treatment   Programs  13%   52  
  • 53. NYC  Department  of  Homeless   Services  (DHS)   More  than  half  DHS  Peace  Officers  are  trained   and  carry  naloxone  in  all  city  shelters   53  
  • 54. NYPD  Naloxone  Project   •  All  NYPD  officers  in  the  120  precinct  on  Staten   Island  (approximately  180)  have  been  trained   to  carry  and  dispense  naloxone   •  Reported  reversals   54  
  • 55. New  York  State  Good  Samaritan  Law   55  
  • 56. Summary   •  Opioid  misuse  and  its  health  consequences   consGtute  a  public  health  crisis   •  MulG-­‐pronged  approaches  are  needed   •  Changing  prescribing  pa2erns  is  key   •  Raising  public  awareness   •  MulG-­‐agency  use  of  naloxone   •  Ensuring  access  to  effecGve  treatment   •  This  problem  is  preventable!   56  
  • 57. Conclusion   •  RxStat  is  a  collaboraGon  between  NYC  public   health  and  public  safety  toward  one  unifying   goal:    Reduce  overdose  deaths  in  NYC   •  Timely/real-­‐Gme  data  informs  comprehensive,   mulG-­‐pronged  responses  to  opioid  analgesic   misuse   57